Evidence map›Paper›PMID 20348952›Full record

ArticleOncogene2010

EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A.

D M Gascoyne, J Dunne, S Behjati, N J Sebire, J Anderson, D S Latchman

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

D M GascoyneMolecular Haematology and Cancer Biology Unit, University College London Institute of Child Health, London, UK. duncan.gascoyne@ndcls.ox.ac.uk
J Dunne
S Behjati
N J Sebire
J Anderson
D S Latchman
Cancer Research UK · GBUniversity College London · GBBirkbeck, University of London · GBGreat Ormond Street Hospital · GB

Funding

Biotechnology and Biological Sciences Research CouncilCancer Research UKMedical Research Council
6 · The paper itself

Abstract

Ewing's sarcoma family tumors (ESFTs or EFTs) express neuronal markers, which indicates they may originate from cells at least partly committed to neuronal lineage. However, recent publications suggest EFT originates in mesenchymal stem cells, and EWS/ETS fusion proteins characteristic of EFT activate neuronal marker expression to confer a neural phenotype on EFT. Here we show that the neuronal marker BRN3A/POU4F1 is expressed abundantly at the protein level in primary EFT but not in rhabdomyosarcoma and neuroblastoma, and EFT cells exhibit high activity of the BRN3A proximal autoregulatory region. EWS/FLI-1 siRNA reduces BRN3A expression and promoter activity and EWS/ETS proteins are bound to the BRN3A locus, suggesting a direct function for EWS/ETS proteins in control of BRN3A expression. Differentiation-associated and autoregulatory activities of BRN3A are respectively impaired and altered in EFT cells, and EWS/FLI-1 siRNA can restore some BRN3A function. A potentially novel function for BRN3A in EFT cells is identified. These results extend the hypothesis that EWS/ETS proteins induce expression of neuronal markers such as BRN3A in EFT by showing that the function of those same markers may be restricted or controlled in an EWS/ETS-dependent manner.

Indexed as

Cell DifferentiationGenes, ReporterHumansLuciferasesNeuroblastomaNeuronsPlasmidsPromoter Regions, GeneticProto-Oncogene Protein c-ets-1Recombinant Fusion ProteinsRhabdomyosarcomaRNA-Binding Protein EWSSarcoma, EwingTranscription Factor Brn-3ALuciferasesProto-Oncogene Protein c-ets-1Recombinant Fusion ProteinsRNA-Binding Protein EWSTranscription Factor Brn-3A

Identifiers

PMID20348952
OpenAlexW2092560218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.